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Despite the fact that the choroid plays an important role in the structure and function of the eye, it has
not been studied in detail in vivo. Improvements in optical coherence tomography (OCT) imaging
technology allow the routine imaging of the choroid and deep optic nerve structures in most patients. As
with any new technology, it needs validation in both healthy and diseased eyes. Reproducible mea-
surements of choroidal and lamina cribrosa thickness are possible. Several variables such as age, axial
length, and time of day, affect choroidal thickness and must be taken into account when interpreting
data on choroidal thickness. Lamina cribrosa thickness appears to be affected by age as well but other
factors need to be determined. Choroidal thickness may be used to differentiate between central serous
chorioretinopathy (CSC), polypoidal choroidal vasculopathy (PCV) and exudative age-related macular
degeneration (AMD). Enhanced depth imaging-optical coherence tomography (EDI-OCT) of the choroid
may detect tumors not detectable by ultrasound. Studying the choroid may help us gain insight into the
pathogenesis of several diseases such as AMD, CSC, glaucoma, posteriorly located choroidal tumors, and
PCV among others.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
The choroid plays an important role in the structure and func-
tion of the normal eye. Most of the ocular blood ﬂow is accounted
for by the choroidal circulation. In fact, the choroid has one of the
highest blood ﬂow rates in the entire body. In addition, the choroid
supplies oxygen and nutrients to the outer retinal layers.1 An un-
derstanding of the pathophysiological changes that occur in the
choroid is of paramount importance in understanding disease of
the posterior segment of the eye.
Despite advances in imaging technology, adequate visualization
of the choroid is still lacking. Traditional imagingmodalities used to
study the choroid such as indocyanine green angiography (ICGA)
and B scan ultrasonography have limitations with regard to image
resolution and measurement accuracy.
Optical coherence tomography (OCT) is a non-invasive, noncon-
tact transpupillary imaging modality that has revolutionizedthalmology Spring Meeting,
or, San José, Costa Rica.
m Heidelberg Engineering.
e Ophthalmologic Society of Taiwophthalmic clinical practice. It utilizes light to image tissue using low
coherence interferometry.2 Time domain OCT does not image the
posterior choroid and sclera adequately. Current commercially
available spectral domain (SD)-OCT systems may be modiﬁed to
allow adequate choroidal imaging.
2. OCT choroidal imaging
There are a few strategies that may improve choroidal OCT
imaging, namely bringing the choroid closer to the zero delay line
using SD-OCT using a light source with a longer wavelength or
using swept source OCT.
During SD-OCT imaging, a beam of low coherence light from a
superluminescent diode is split through a beam splitter into a
sample and a reference beam. Light from the sample beam is
directed toward the tissue of interest, in this case the posterior
segment of the eye, and depending on the composition of the
internal tissue structures, the sample beam will be reﬂected to-
wards the detector with different echo time delays. The reference
beam is reﬂected from a reference mirror towards another de-
tector. Both reﬂected beams of light are compared and combined
into an interference pattern by a modiﬁed Michelson interferom-
eter, called the spectral interferogram or spectrometer.2,3 Fourier
equations transform this spectral interferogram into two OCTan. Published by Elsevier Taiwan LLC. All rights reserved.
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of these images. By convention, the image depicted places the
vitreous at the top of the screen and the choroid towards the
bottom of the screen. In this position, the vitreous is at the peak of
the OCT sensitivity curve and closer to the zero delay line.4,5 When
an OCT instrument is positioned closer to the eye, the inverted
mirror image is obtained and the choroid approaches the zero
delay line. This inverted mirror image has more information from
the deep choroid than the normal noninverted image (Fig. 1). Eye
tracking and image averaging capability are important features
that improve the signal-to-noise ratio with resulting improvement
of visualization of the choroid. In order to obtain the best quality
image, it is important to try to keep the image straight and to keep
the inverted image close to the top of the screen. Spaide and
collaborators 4,5 coined the term enhanced depth imaging (EDI) to
describe this novel choroidal OCT imaging technique using the
Spectralis (Heidelberg Engineering, Heidelberg, Germany) OCT
system. The most recent Spectralis software version makes EDI
even more user friendly by incorporating EDI into the scanning
protocols. Therefore, all the operator needs to do is press the EDI
button, and the software automatically inverts the image. Image
averaging, eye tracking, high-speed scanning, and low speckle
noise produce high-quality choroidal images with the EDI mode in
the Spectralis OCT.
Most commercially available OCT systems use a light source of
approximately 800 nm, which penetrates the choroid and sclera
poorly. Both the photoreceptor and retinal pigment epithelium
(RPE) layers scatter the 800-nm light signal, resulting in a weak
signal from the choroid (Fig. 1). An investigational OCT device that
uses a light source of 1060 nm has been developed. The longer
wavelength of the light source permits a higher penetration and
visualization of the choroidoscleral interphase allowing accurate
measurement of the choroidal thickness.6Fig. 1. Comparison between conventional Spectralis optical coherence tomography
(OCT) scanning and enhanced depth imaging (EDI) OCT scanning of the macula of the
same patient. (A) EDI-OCT showing choroidal details and the choroidal scleral inter-
phase. (B) Conventional OCT showing no choroidal details.Swept source OCT is another device that uses a frequency swept
laser with a narrowband light source that is rapidly tuned over a
broad optical bandwidth that enables the measurement of inter-
ference at different optical frequencies or wavelengths sequentially
over time.7 No spectrometer or line camera is needed for the
Fourier transformation. This increases the imaging speed up to
300,000 axial scans per second and allows a deeper penetration of
the sampling beam.
Choroidal imaging and thickness measurements have been re-
ported with several commercially available OCT systems including
the Cirrus (Carl Zeiss Meditec Inc, Dublin, CA), Topcon 3DOCT 2000
(Topcon Corporation, Tokyo, Japan), Optovue RTVue (Optovue Inc,
Fremont, CA), Bioptigen (Bioptigen Inc, Research Triangle Park, NC,
USA) and the Heidelberg Spectralis.4,5,8 Not all machines are
created equally. For instance, the Cirrus OCT system lacks eye
tracking ability, and hence the averaging of the images is less likely
to improve the signal-to-noise ratio. Furthermore, with Cirrus, it is
unclear where the image is placed within the sensitivity curve.9 As
a matter of fact, with the Cirrus it is important not to bring the
choroid to the zero delay line since image inversion with the Cirrus
software results in images of very low quality.8 Lin et al10 compared
the choroidal thickness, visualization of the choroido-scleral junc-
tion, and visibility of the large outer choroidal vessels across several
SD-OCT systems using upright and inverted images. They reported
that the most favorable modes to visualize choroidal details were
Spectralis in either EDI or inverted mode, Bioptigen in the inverted
mode and Cirrus in upright mode. They also stated that choroidal
thickness cannot be compared between machines because of
different conversion factors.10
3. Choroidal thickness in normal eyes
There is currently no automated segmentation software that is
commercially available to measure the choroidal thickness.
Therefore, once the EDI-OCT image is obtained, the choroidal
thickness needs to be measured manually by using calipers to
measure the distance from the outer border of the RPE to the inner
surface of the sclera (Fig. 2). Investigators have recently unveiled anFig. 2. There is currently no automated segmentation software available tomeasure the
choroidal thickness in the Spectralis machine. Therefore, once the EDI-OCT image is
obtained, the choroidal thickness needs to be segmented semi-automatically using the
built-in automated retinal segmentation software on the Spectralis SD-OCT. By using
the software of the Heidelberg spectralis we have manually moved the lines of the ILM
to the RPE and the RPE to the chorioscleral junction. The retinal boundary reference
lines placed by the built-in automated segmentation software were moved to the
choroidal boundaries. BM ¼ Bruch’s membrane; EDI-OCT ¼ enhanced depth imaging-
optical coherence tomography; ILM ¼ internal limiting membrane; RPM ¼ retinal
pigment epithelium; SD-OCT ¼ spectral domain-optical coherence tomography.
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ware automatically separates the choriocapillaris from the
choroidal vasculature.11 Additional studies need to be performed to
validate the use of this software.
There is considerable inter-individual variability in choroidal
thickness.12 Choroidal thickness measurements in normal subjects
appear to be highly reproducible.5,13,14 A change of >32 mm in
subfoveal choroidal thickness probably exceeds interobserver
variability.13 Chlhaablani et al15 have shown that measurements of
choroidal volume by manual segmentation using the built-in
automated retinal segmentation software on Spectralis SD-OCT
are highly reproducible and have a low level of variability. Prior
to utilizing choroidal thickness as a parameter to monitor disease
conditions, normal physiological parameters that affect choroidal
thickness need to be identiﬁed.
Choroidal thickness exhibits regional variations across the pos-
terior pole. It varies according to macular location. Margolis and
colleagues4 performed EDI-OCTof the posterior polewith 7 sections
within a 5  30 degree area centered at the fovea, with 100 scans
averaged for each section. Theymeasured the choroidal thickness in
this area and reported that the choroidwas thinnest nasally, thickest
subfoveally, and thinner temporally. The inferior macular choroid
was also thinner than the superior macular choroid.4,8 In another
study, choroidal volumes were calculated using an investigational
devicewith a 1050-nm light source.12 They used an Early Treatment
of Diabetic Retinopathy Study (ETDRS) 6 mm  6 mm grid that was
superimposed in the posterior pole to delineate 9macular subﬁelds.
The thickest choroid was found in the outer superior subﬁeld,
whereas the thinnest choroidwas located in theouternasal subﬁeld.
In addition, they reported a greater correlation between the
choroidal thickness and the distance from the optic nerve head
rather than the distance from the fovea. The authors of this study
suggest that the optic nerve head might be a better reference point
than the foveal center to study regional differences in choroidal
thickness. The only exception was inferonasal section of the disc,
where the most pronounced choroidal thinning was present.12
Ikuno et al16 have hypothesized that the presence of a vascularFig. 3. Comparison between enhanced depth imaging-optical coherence tomography scan
thickness of 356 mm. (B) An 83-year-old woman with subfoveal choroidal thickness of 139watershed zone and the embryonic location of the optic ﬁssure
closure are responsible for this choroidal thinning. Ouyang et al12
support this hypothesis and propose that this choroidal thinning
inferonasal to the disc is a relative coloboma that all healthy eyes
exhibit as a remnant of normal embryological development.
Age is another variable that needs to be taken into account when
comparing choroidal thickness.4,12 In normal eyes, progressive
choroidal thinning occurs over time at a rate of 1.56 mm per year in
the subfoveal area4 (Fig. 3). Themean subfoveal choroidal thickness
in normal eyes has been reported to be 287e332 mm. The difference
between studies is probably because of the difference in mean age
in these studies.5,12,13
The axial length and refractive status also appear to inﬂuence
choroidal thickness. There is an inverse relation betweenmyopia and
choroidal thickness12,17 (Fig. 4). Choroidal thickness decreased
almost 32 mm for every 1 mm increase in axial length.12 In highly
myopic eyes (>6 D) and no observable fundus changes, subfoveal
choroidal thickness decreased by 12.7 mm for each decade of life and
by 8.7 mmfor each diopter ofmyopia.17 Subfoveal choroidal thickness
is an important predictor of visual acuity in highly myopic eyes.18
Gender might play a role in choroidal thickness. Li et al19 re-
ported that women have a thinner choroid than men. In contrast,
Chen et al20 did not ﬁnd any gender related differences in choroidal
thickness.
Since a large portion of the choroid is comprised by vascular
structures, it is conceivable that hemodynamic variables affect
choroidal thickness. In one study, the total choroidal blood ﬂow and
the subfoveal choroidal blood ﬂow did not appear to affect sub-
foveal choroidal thickness.21 In contrast, a recent study showed that
ocular perfusion pressure might be associated with subfoveal
choroidal thickness in young healthy individuals.22 Acute changes
in systolic blood pressure induced by exercise did not affect sub-
foveal choroidal thickness either.23
Diurnal ﬂuctuations in choroidal thickness have recently been
described.24,25 The choroid appears to be thicker at night and
thinner during the day. These ﬂuctuations appear to be associated
with age, axial length, refractive error, and systolic blood pressure.24s in two patients of different ages. (A) A 12-year-old boy with a subfoveal choroidal
mm.
Fig. 4. Comparison of enhanced depth imaging-optical coherence tomography scans according to refractive status. (A) A 38-year-old womanwith no refractive error and a subfoveal
choroidal thickness of 276 mm. (B) A 36-year-old woman with 8 D of myopia and a subfoveal choroidal thickness of 77 mm.
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McCourt et al26 compared the subfoveal choroidal thickness in
eyes with different ophthalmic pathologies and compared it to a
normal cohort. They reported that eyes with glaucoma, diabetic
retinopathy, and age-related macular degeneration (AMD) had a
signiﬁcantly thinner choroid than normal patients. However, when
age was taken into account as a confounding variable, theFig. 5. Differentiation between AMD and CSC using choroidal thickness. In general, patients
thinner choroid. (A) A 67-year-old woman with active CSC. Subfoveal choroidal thickness
thickness of 139 mm. AMD ¼ age-related macular degeneration; CSC ¼ central serous chordifferences disappeared underscoring the effect that aging plays in
determining choroidal thickness.
5. Central serous chorioretinopathy
Central serous chorioretinopathy (CSC) is thought to arise from
choroidal vascular hyperpermeability.27 Several studies have used
EDI-OCT and swept source SD-OCT to demonstrate that in CSC, thewith CSC tend to have a thicker choroid. Conversely, patients with AMD tend to have a
is 305 mm. (B) A 71-year-old woman with exudative AMD and a subfoveal choroidal
ioretinopathy.
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constructed choroidal macular maps by manually segmenting
choroidal thickness and then using the bundled automated soft-
ware to measure the volume between the segmented lines. They
showed that the increased choroidal thickness seen in CSC was a
diffuse phenomenon throughout the macular area and not limited
to focal points.30 Interestingly enough, choroidal thickness is usu-
ally increased in both the affected and the fellow eye.28,32 This is in
agreement with the indocyanine green angiography (ICGA) ﬁnd-
ings that show bilateral vascular choroidal hyperpermeability even
in the eyeswithout subretinal ﬂuid.33 This lends further credence to
the hypothesis that an increased choroidal hydrostatic pressure
plays an important role in the pathogenesis of this disease.
Following the successful treatment of active CSC with either full- or
half-ﬂuence photodynamic therapy, the choroidal thickness was
found to decrease.29e31 In eyes treated successfully with laser
photocoagulation, leakage resolved, but the choroidal thickness
remained high.29,30 EDI-OCT of the choroid has documented that
sildenaﬁl citrate increases choroidal thickness and thus may be a
risk factor for CSC.34,35 Alternatively, sildenaﬁl might be used as a
treatment in those conditions that would beneﬁt from an increased
choroidal blood ﬂow.35
6. Age-related macular degeneration
The pathogenesis of the disease process in age-related macular
degeneration (AMD) is not completely understood. Multiple envi-
ronmental, dietary, and genetic factors appear to play a role in this
condition. Theories from chronic inﬂammation to ischemia have
been proposed.36e38 With aging, there is an increasing lipoid
deposition in the sclera, choroid, and Bruch’s membrane.39 Ac-
cording to Friedman,37 this deposition leads to an increased resis-
tance to choroidal blood ﬂow and decreased choroidal perfusion,
which may contribute to the development of AMD. High resolution
OCT imaging of the choroid may shed some light in this regard.
There have been conﬂicting reports with regard to choroidal
thickness in patients with early AMD.40,41 In one study, choroidal
thickness was found to be similar between 16Welsh eyeswith early
AMD and 16 eyes in an age-matched control.40 In another study of
17 Korean eyes with early AMD, choroidal thickness was less than
that of the age-matched control eyes.41 Manjunath et al42 reported
that in eyes with AMD, choroidal thickness was variable. This may
be due to the fact that they used Cirrus SD-OCT, and only 38% of
their sample could be imaged reliably and included in the study. In
their study, eyes with AMD on average had a thinner choroid than
that of normal controls. Furthermore, eyes with exudative AMDhad
thinner choroids than eyes with nonexudative AMD.42 Switzer
et al43 explored the relationship between different phenotypes
seen in early AMD and choroidal thickness. They reported that eyes
with fundus tessellation, b zone peri-papillary atrophy, absence of
conventional drusen, sub-retinal drusenoid deposits (SRDD), open
angle glaucoma, or an absence of the contact cylinder band on SD-
OCT had a thinner choroid than eyes without these features.43
Reticular pseudo-drusen or SRDD confers an increased risk for
the development of late AMD.44 The main ﬁnding of the histo-
pathological examination of an eye with SRDD was the loss of the
small choroidal vessels with an increased spacing between the
large choroidal veins. The authors of this report proposed that the
choroidal stroma was replaced by ﬁbrous tissue in a reticular
pattern.45 Prior to EDI-OCT of the choroid, it was not possible to
verify this hypothesis. Choroidal EDI-OCT has shown that eyes with
SRDD appear to have a thinner choroid than eyes with early
AMD.43,46 In one study, interestingly enough, the choroid was
thinner in all points tested, except superior to the fovea. Multi-
modality imaging showed that the areas of increased choroidalthickness correlated with the physical presence of SRDD.46 It may
well be that in eyes with SRDD, initially there is a diffuse loss of
small choroidal vessels which lead to choroidal thinning. Later, the
choroidal stromal is replaced by ﬁbrous tissue which leads to a
relative choroidal thickening. This replacement occurs predomi-
nantly in the area of SRDD, which happens to be in the superior
macula.46 Given the cross-sectional nature of these studies, it re-
mains unclear if choroidal thinning causes reticular pseudodrusen
or the presence of pseudodrusen contributes to choroidal thinning.
In eyes with exudative AMD, the subfoveal choroidal thickness
has been reported to be thinner than eyes with polypoidal
choroidal vasculopathy (PCV).41,47e49 One group of investigators
went one step further and correlated choroidal hyperpermeability,
as seen on ICGA, with choroidal thickness.47 In this study, some
eyes with exudative AMD exhibited choroidal hyperpermeability
and some eyes did not have choroidal hyperpermeability. In pa-
tients with exudative AMD with choroidal hyperpermeability,
subfoveal choroidal thickness did not differ between eyes with
AMD and PCV. Conversely, in eyes with no choroidal hyper-
permeability, the subfoveal choroidal thickness in eyes with PCV
was signiﬁcantly higher than that in eyes with AMD. In patients
with unilateral disease, the fellow eyes had similar choroidal
thickness as the involved eyes.47 An association between the I62V
polymorphism in the complement factor H (CFH) gene and
choroidal thickness in eyes with PCV was identiﬁed in a Japanese
study. Other polymorphisms such as the Y402H in the CFH gene
and the A69S in the ARMS2 gene were not associated with sub-
foveal choroidal thickness. Since CFH regulates the alternative
complement system, inﬂammation may play a role in the choroidal
changes seen in PCV.47
The above ﬁndings suggest different underlying pathophysio-
logical mechanisms between PCV and AMD. Two schools of thought
regarding the pathogenesis of PCV currently exist. According to
some, the choroidal vascular lesion seen in PCV is a variant of
CNV.50 Others propose that the choroidal vascular abnormalities
seen in PCV are distinct from CNV.51
CSC and PCV are often difﬁcult to differentiate from AMD,
particularly in older patients. Since treatment for these conditions
vary, it is important to make this distinction. Measuring the
choroidal thickness may help differentiate between exudative AMD
and PCV and between exudative AMD and CSC.41,47e49 Both PCV
and CSC eyes have thicker choroids than those in normal in-
dividuals. Conversely, eyes with exudative AMD have thinner
choroids (Fig. 5). The distinction between CSC and PCV can be
difﬁcult at times, since they share many clinical and angiographic
features. Yannuzzi et al52 reported that patients with PCV may
masquerade as CSC and recommended ICGA to differentiate be-
tween these conditions. Typical ICGA ﬁndings of PCV include a
branching network of inner choroidal vessels with nodular aneu-
rysmal hyperﬂuorescence at the edge of this vascular network.53
ICGA has shown that eyes with PCV exhibit choroidal vascular
hyperpermeability, whichmay result in an increased intrachoroidal
hydrostatic pressure.30,54 Similar ICGA choroidal vascular hyper-
permeability ﬁndings have been described in eyes with CSC.30,54 It
is plausible that both PCV and CSC share common pathophysio-
logical mechanisms. Recently, Ooto et al55 used SD-OCT to show
that the photoreceptor outer segments were much thinner in PCV
eyes than those in CSC eyes.
The treatment effects on choroidal thickness remain unclear. In
one study, eyes with exudative AMD that were treated with anti-
VEGF agents had a trend towards thinner choroids when
compared to treatment naive eyes.41 In contrast, Jirarattanasopa
et al47 reported that choroidal thickness decreased in both PCV
and AMD eyes if treated with a combination of verteporﬁn
photodynamic therapy and intravitreal ranibizumab. Eyes treated
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ness. In another study, eyes with exudative AMD that were treated
with intravitreal ranibizumab had a decrease in choroidal
thickness.56
The pathogenesis of a pigment epithelial detachment (PED)
associated with exudative AMD has been a subject of controversy
for several years. On the one hand, Gass proposed that a PED arises
from either serous exudation from choriocapillaris hyper-
permeability through an intact Bruch’s membrane or as a conse-
quence of choroidal neovascularization (CNV) with secondary
exudation directly into the sub-RPE space. On the other hand, Bird
and Marshall57 proposed that increasing lipid deposition into
Bruch’s membrane rendered it hydrophobic and blocked the
normal passage of ﬂuid.58,59 The build-up of ﬂuid would create a
PED. Furthermore, they stated that if CNV occurred it would be as a
consequence of the PED and not the other way around.57e59 Part of
the reason why it has been difﬁcult to study the pathogenesis of
PED is the fact that there are no adequate histopathological studies.
In addition, imaging modalities such as OCT characteristically
reveal an empty hyporeﬂective space in the internal structure of a
serous PED. Given the limitations of conventional OCT choroidal
imaging, it was unclear if the optically empty space was really
optically empty or was ﬁlled with material that simply was not
imaged due to its location deep down in the choroid. Spaide60 used
EDI-OCT to demonstrate that PEDs were often ﬁlled with material
suggestive of choroidal neovascularization lending support to
Gass’s theory of neovascular origin for PEDs (Fig. 6). Coscas et al61
have recently used en face EDI-OCT to image ﬁbrovascular PED.
They reported clear CNV visualization and localization within the
ﬁbrovascular PED.Fig. 6. Comparison between conventional Spectralis optical coherence tomography
(OCT) scanning and enhanced depth imaging (EDI) OCT scanning of an eye with a
pigment epithelial detachment (PED) associated with exudative age-related macular
degeneration. (A). Conventional Spectralis OCT scanning. Note the optically empty area
under the PED. (B). EDI Spectralis OCT imaging of the same patient. Note that the area
under the PED is no longer optically empty suggesting neovascularization (arrow).7. Age-related choroidal atrophy
Spaide62 used EDI-OCT to describe a new clinical entity, age-
related choroidal atrophy. In his cohort of 28 patients, the mean
visual acuity was 20/40, the mean age was 80.6 years, and all eyes
had a tessellated fundus appearance. Close to a third of the eyes
suffered from concurrent late AMD. Glaucomawas present in over a
third of the patients. The mean subfoveal choroidal thickness was
only 70 mm. The loss of choroidal thickness was associated with the
loss of visible vessels, implying that age-related choroidal atrophy
is a manifestation of small-vessel disease affecting the choroid.62
8. Vogt-Koyanagi-Harada Syndrome
The Vogt-Koyanagi-Harada (VKH) syndrome is characterized by
an autoimmune response against melanin containing tissues. Since
the choroid contains most of the melanocytes in the eye, it is often
targeted in this condition. Eyes with acute disease exhibit a granu-
lomatous choroidal inﬂammatory inﬁltrate that thickens the
choroid.63 Both ultrasonography and ICGA have been used to
monitor response to therapy by assessing the choroid. Their main
limitation is the inability to analyze thedata in aquantitative fashion.
EDI-OCT measured choroidal thickness might be used longitu-
dinally as a surrogate marker of disease activity in the Vogt-
Koyanagi-Harada (VKH) syndrome.64e66 Eyes with new onset
acute disease manifest markedly increased choroidal thickness.
Once the inﬂammation is brought under control, choroidal thick-
ness decreases rapidly.64,66,67 This decrease in choroidal thickness
has been correlated with a decreasing height of the serous retinal
detachment and visual improvement.64,67 Choroidal thickness in
excess of 550 mmat 1week after initiating treatment correlateswith
the development of peripapillary atrophy.67 Peripapillary atrophy in
VKH has been associated with retinal dysfunction and inadequate
immunosuppressive therapy.68,69 Nakayama et al67 speculated that
a thicker choroid represents a greater inﬂammatory burden that
causes a greater tissue destruction acutely, resulting in a greater
atrophy in the convalescent phase.
If a recurrence occurs, the choroid becomes thickened again.65,67
During the convalescent stage, the mean choroidal thickness is
thinner in VKH eyes than normal control eyes, particularly in eyes
with a sunset glow fundus appearance.65 A prospective case control
study compared choroidal thickness in eyes with long standing
VKH (deﬁned as>6months duration) with an aged control group.70
The choroid was signiﬁcantly thinner in eyes with VKH compared
to normal controls. There was no difference in choroidal thickness
in eyes with and without clinical inﬂammation, which is in stark
difference to eyes with new onset acute disease. This chronic
choroidal thinning is most likely the result of choroidal atrophy.
EDI-OCT of the choroid has enabled observers to report a loss of
focal hyperreﬂectivity in the inner choroid of eyes with VKH in both
the acute and convalescent stages. These inner choroidal hyper-
reﬂective foci probably represent small choroidal vessels.66 Their
loss during the acute stage might be secondary to compression by
granulomas and nonperfusion caused by the massive inﬂammatory
inﬁltration. ICGA has shown ﬁlling delays of the choriocapillaris.71
In an ICGA pathological correlation, hypoperfused black spots,
presumed to be granulomas, were seen compressing the chorio-
capillaris.72 During the convalescent stage, stromal scarring and
loss of small vessel disease results in tissue loss, which is man-
ifested as choroidal thinning.66
9. Macular holes
Idiopathic macular holes are thought to arise from abnormal
vitreomacular traction.73 Recent EDI-OCT studies have suggested
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studies, the subfoveal choroidal thickness of eyes with full thick-
ness idiopathic macular hole were compared with the nonaffected
fellow eye and controls. In general, subfoveal choroidal thickness in
eyes with the macular hole and in the healthy fellow eye is thinner
than control eyes. There was no correlation between subfoveal
choroidal thickness and the diameter of the hole in one study.74 In
the other study, a trend was seen for a thinner choroid to be
associated with a larger macular hole.75 In contrast, Schaal et al76
did not ﬁnd any differences in choroidal thickness between eyes
with macular hole and control eyes. These observations if real,
suggest that bilateral thinning of the choroid may precede macular
hole formation. Over 25 years ago, Morgan and Schatz77 proposed
that involutional macular thinning was an important step in the
pathogenesis of idiopathic macular hole. Given the cross-sectional
nature of these studies, it remains unclear whether choroidal
thinning is the result or the cause of idiopathic macular hole.
10. Inherited retinal diseases
Retinitis pigmentosa refers to a group of inherited disorders
caused by multiple genetic defects that manifest progressive
photoreceptor degeneration. In retinitis pigmentosa there is a
marked reduction in choroidal blood ﬂow and velocity, which
correlates with disease severity.78,79 Currently there is no treat-
ment available. Among the experimental therapies being explored,
visual prostheses are being studied as means to restore some visual
function in end-stage eyes. In order to design appropriate supra-
choroidal implants, accurate choroidal thickness measurements are
needed in order to calculate the distance between the implant and
the ganglion cell layer.80
On EDI-OCT patients with retinitis pigmentosa have signiﬁ-
cantly thinner choroids than normal individuals.81,82 Ayton et al81
reported that patients with the worse visual acuity and a longer
history of symptoms had signiﬁcantly thinner choroids. In contrast,
Dhoot and colleagues82 found that there was no correlation be-
tween visual acuity and choroidal thickness. They also reported
choroidal thinning in eyes with relatively good visual acuity sug-
gesting that choroidal blood ﬂow abnormalities rather than
photoreceptor degeneration are responsible for such thinning.
A retrospective observational case series consisting of 20 eyes
with a variety of inherited retinal diseases such as Best disease,
Stargardt, choroidoremia, peripherin retinal degeneration slow
(RDS) mutations, and Bietti crystalline retinal dystrophy reported
that the degree of choroidal thinning depended on the underlying
condition and also in the stage of the disease.83 For instance, in
early Stargardt disease, there was no choroidal thinning but in
advanced cases choroidal thinning was present. The authors sug-
gest that in diseases limited to the macula, focal choroidal thinning
was probably secondary to choriocapillaris atrophy caused by RPE
death. In contrast, as expected, diffuse choroidal thinning was seen
in eyes with choroidoremia. In this study, there was no correlation
between choroidal thinning and visual acuity, extent of retinal
dysfunction or electrophysiological ﬁndings.83
11. Diabetic retinopathy
Despite the fact that diabetes mellitus also affects the choroid,84
little is known clinically about diabetic choroidopathy. Diabetic
patients with diabetic retinopathy appear to have a thinner
choroid.85e89 However, it remains unclear if the degree or severity
of diabetic retinopathy inﬂuences choroidal thickness. According to
an observational comparative study that used the Nidek Retinascan
RS 3000 SD-OCT (Gamagori, Japan), choroidal thickness was indi-
rectly proportional to the degree of diabetic retinopathy. Thechoroidal thickness in diabetic eyes without retinopathy did not
differ from normal control eyes. In addition, there was no correla-
tion observed between macular edema and choroidal thickness or
between choroidal and retinal thickness.85 In another study using
Cirrus SD-OCT, there was no difference in choroidal thickness in
eyes with nonproliferative diabetic retinopathy and normal control
eyes. Interestingly, eyes with diabetic macular edema and treated
eyes with proliferative diabetic retinopathy exhibited thinner
choroids than their normal counterparts.87 Querques et al86
investigated the changes in macular choroidal thickness in a se-
ries of 63 diabetic eyes with the Spectralis SD-OCT. They compared
diabetic eyes with no retinopathy, nonproliferative diabetic reti-
nopathy with no macular edema and nonproliferative diabetic
retinopathy with macular edema. They reported that there was no
difference in the subfoveal choroidal thickness in the different
diabetic groups. Since choroidal blood ﬂow is compromised in
diabetic patients,90 Querques and colleagues86 suggest that a
decreased choroidal blood ﬂow is related to the decrease in
choroidal thickness. According to them, diabetes mellitus (DM)
may cause choriocapillaris atrophy, which in turn leads to an in-
crease in vascular resistance and a decrease in choriocapillaris
blood ﬂow. The impaired choriocapillaris blood ﬂow may lead to
macular hypoxia and vascular endothelial growth factor (VEGF)
secretion, thus contributing to the pathogenesis of diabetic macular
edema.86,87 Three-dimensional 1060-nm OCT choroidal thickness
maps revealed that the central and inferior choroid were thinner in
diabetic eyes as compared to normal controls. In this study,
choroidal thickness was also indirectly proportional to the degree
of diabetic retinopathy. Diabetic eyes without retinopathy had
similar choroidal thickness as the controls.88,89 It remains unclear
what causes choroidal thinning since the choroidal thinning ex-
ceeds the magnitude of choriocapillaris atrophy.88 Choroidal EDI-
OCT imaging might be an useful method to study the contribu-
tion of the choroidal circulation to the overall visual dysfunction
seen in diabetic patients.
12. Glaucoma
The basic pathophysiological mechanisms of glaucoma remain
unknown. According to one theory, glaucomatous optic nerve
damage occurs as a result of an ischemic insult following a reduced
blood ﬂow at the level of the lamina cribrosa. Since the choroid is
the intraocular tissue that carries the highest blood ﬂow, there has
been interest in studying what role if any the choroid might play in
the pathogenesis of glaucoma.
Histopathological studies of autopsy eyes suggest that the
choroid is thinner in glaucomatous eyes.91,92 Yet in vivo studies with
EDI-OCT have not substantiated these ﬁndings.93e96 Mwanza and
colleagues94 have reported that the choroidal thickness as
measured with EDI-OCT is similar among normal, normal tension
glaucoma and primary open angle glaucoma eyes. Similar ﬁndings
were reported by Fenolland et al.95 Arora et al97 did not ﬁnd any
signiﬁcant differences in choroidal thickness between eyes with
open angle glaucoma and normal controls. Maul et al93 reported
that choroidal thickness did not differ in eyes with glaucoma and
eyes that were suspicious for glaucoma. Furthermore, no correla-
tion between choroidal thickness and glaucoma damage could be
documented.93,96 Central corneal thickness and diastolic perfusion
pressure are variables that affect choroidal thickness in glaucoma
and glaucoma suspect eyes.93
The choroid is thicker in angle closure than in open angle and
control eyes.97 Rapid drinking of 1 L of water over 30 minutes in-
duces signiﬁcant increases in intraocular pressure and choroidal
thickness in eyes with angle closure glaucoma. This may signify
that in eyes with angle closure, the choroid has a greater tendency
Fig. 7. Comparison between conventional Spectralis optical coherence tomography (OCT) scanning and enhanced depth imaging (EDI) OCT scanning of the optic nerve of the same
patient. (A) Conventional OCT of the optic nerve region. (B) EDI-OCT of the same patient demonstrating better detail of the lamina cribrosa and adjacent structures. 1 ¼ anterior
border of the lamina cribrosa; 2 ¼ posterior border of the lamina cribrosa; 3 ¼ central retinal vein; 4 ¼ chorioscleral junction.
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that the increased intraocular volume secondary to choroidal
expansion leads to an immediate increase in intraocular pressure.
As a compensatory mechanism, aqueous outﬂow across the
trabecular meshwork increases to try to restore normal intraocular
pressure. As ﬂuid leaves the anterior chamber, the aqueous volume
of the anterior chamber diminishes, creating a posterior to anterior
pressure gradient. As a result, the lens moves forward, making the
iris lens channel narrower and increasing resistance to pupillary
aqueous ﬂow. At the same time, the iris bows forward and occludes
the trabecular meshwork. Thus, in eyes with a narrow angle, dy-
namic choroidal expansion may contribute to angle closure.
In addition biomechanical factors such as the translaminar
pressure gradient (TLPG) and the translaminar pressure difference
(deﬁned as intraocular pressure minus the cerebrospinal ﬂuid
pressure) may contribute to optic nerve injury in glaucoma. An
elevated TLPG blocks axoplasmic ﬂow across the lamina cribrosa,
causing axonal injury.99 The translaminar pressure difference has
been associated to neuroretinal rim area and visual ﬁeld defect.100
The TLPG is directly related to the translaminar pressure difference
and inversely related to the lamina cribrosa thickness.101Fig. 8. Enhanced depth imaging of a choroidal nevus. Note the hyper-reEDI-OCT imaging has allowed the in vivo study of the human
optic nerve head and surrounding structures such as the lamina
cribrosa, short posterior ciliary arteries, central retinal artery, cen-
tral retinal vein, the peripapillary choroid, peripapillary sclera, and
the subarachnoid space around the optic nerve.102,103 (Fig. 7) The
central retinal vein and artery were seen in all eyes. In high myopia,
the subarachnoid space around the optic nervemay also be imaged.
The lamina cribrosa was well identiﬁed in most eyes. Its anterior
surface was seen in part in all eyes, whereas the pores were
detected in over three-fourths of eyes. Given the difﬁculty in im-
aging the posterior border of the lamina cribrosa, Lee and col-
leagues101 have proposed using thin slab maximum intensity
projection image to improve the reproducibility of the lamina cri-
brosa EDI-OCT measurements.
EDI-OCT imaging of the human optic nerve head may prove to
be useful in studying the pathogenesis of glaucoma.102,103 In a
group of healthy individuals, the thickness of the central lamina
cribrosa correlated with age but did not correlate with axial length
or central corneal thickness.104 It appears that the lamina cribrosa is
thinner in glaucomatous eyes when compared to glaucoma sus-
pects or normal controls.102,105 A recent study demonstrated that anﬂective band within the choriocapillaris with posterior shadowing.
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displacement in the lamina cribrosa of glaucomatous eyes or
normal control eyes.106 In contrast, glaucomatous eyes that un-
derwent surgical intervention to reduce intraocular pressure,
manifested anterior laminar displacement and thickening of the
prelaminar tissue.107 These different ﬁndings have been attributed
to the differences in intraocular pressure change and duration plus
the differences in the study populations.108
13. Tumors
Small choroidal tumors located in the posterior pole that are not
detectable by ultrasoundmay be imaged and studied by EDI-OCT109
(Fig. 8). In contrast, larger tumors (>1 mm in height or >9 mm in
diameter) are not appropriate for EDI-OCT since the borders of the
tumors fall beyond the boundaries of the instrument. Certain
characteristic features have been described. Both melanomas and
choroidal nevi had a highly reﬂected band within the chorioca-
pillaris that caused posterior shadowing of the underlying struc-
tures. The presence of choroidal vascular spaces of normal caliber
differentiates a nevus from a melanoma. In a retrospective
comparative study of choroidal nevi and small choroidal mela-
noma, Shields et al110 demonstrated that ultrasound overestimated
tumor thickness by 55% in small choroidal melanoma. EDI-OCT
features that differentiated small choroidal melanoma from
choroidal nevi included increased tumor thickness, the presence of
subretinal ﬂuid, subretinal lipofuscin deposition, and retinal ir-
regularities. EDI-OCT demonstrate that the majority of choroidal
nevi have overlying choriocapillaris thinning111 (Fig. 8).
An EDI-OCT with a low reﬂective band in the posterior choroid
with enlargement of the suprachoroidal space suggests choroidal
metastasis.109 Circumscribed choroidal hemangiomas were char-
acterized by a homogeneous signal of low to medium reﬂectivity
with large intrinsic spaces.109 Thus, EDI-OCT and ultrasound may
serve as complementary ancillary exams in the management of
posteriorly located choroidal tumors.
14. Conclusions
In summary, EDI-OCT is a reproducible technique that allows
imaging of the choroid and deep optic nerve structures. Repro-
ducible measurements of choroidal and lamina cribrosa thickness
are possible. Several variables such as age, axial length and time of
day affect choroidal thickness andmust be taken into account when
interpreting the data on choroidal thickness. Lamina cribrosa
thickness appears to be affected by age as well but other factors
need to be determined. Choroidal thickness may be used to
differentiate between CSC, PCV, and exudative AMD. EDI-OCTof the
choroid may detect tumors not detectable by ultrasound. Studying
the choroid may help us gain insight into the pathogenesis of
several diseases such as AMD, CSC, glaucoma, posteriorly located
choroidal tumors, and PCV among others. Limitations of current
techniques include the lack of automated segmentation software
but improvements are in the horizon. We are just really beginning
to explore the depths of the choroid and optic nerve. With im-
provements in technology, we can only imagine what the future
will bring.
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